<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04799366</url>
  </required_header>
  <id_info>
    <org_study_id>H-18023049-1</org_study_id>
    <nct_id>NCT04799366</nct_id>
  </id_info>
  <brief_title>Contractile Properties of Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia</brief_title>
  <official_title>Contractile Properties of Hypertrofic Muscles in Patients With Non-Dystrophic Myotonia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In myotonia congenita (MC), mutations in the CLCN1 gene coding a key chloride channel&#xD;
      expressed in muscle cells cause myotonia. On examination, the myotonia can be demonstrated as&#xD;
      delayed muscle relaxation of muscle contractions after mechanical stimulations. Existing&#xD;
      literature describe no muscle weakness in MC patients, however a recent muscle MRI study in&#xD;
      non-dystrophic myotonia patients found structural abnormalities in affected muscles when&#xD;
      examined using T1 and STIR imaging. The question remains whether the signs of structural&#xD;
      changes in the muscle are merely due to the myotonia, or long-term effects of elevated stress&#xD;
      of the tissue, and if so, whether those changes lead to clinically significant loss of&#xD;
      contractile properties of the muscle.&#xD;
&#xD;
      This study examines if the contractile properties of myotonic muscles are impaired in MC&#xD;
      patients. 40 patients with Thomsens disease (n=20) and Beckers disease (n=20), respectively,&#xD;
      will be included along with 20 healthy controls. Peak muscle torque is measured in the hand&#xD;
      by hand dynamometer and in the thigh and calf muscles with a Biodex System 4 Pro Dynamometer&#xD;
      and the cross-sectional area of the muscles are examined on T1-weighed and Dixon-MRI-scan.&#xD;
      With the obtained data peak torque in strength tests, muscle hypertrophy, fat fraction in&#xD;
      muscle tissue and contractility of the muscles, compared with healthy controls, will be&#xD;
      assessed.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Contractile properties</measure>
    <time_frame>1 year</time_frame>
    <description>To investigate if contractile properties of the muscles are impaired in MC patients compared with healthy controls.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measuring muscle hypertrophy in upper and lower limbs</measure>
    <time_frame>1 year</time_frame>
    <description>Visualizing and measuring hypertrophy on MRI of affected muscles in the forearm, thigh and calf of MC patients compared with muscles in healthy controls.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Non-Dystrophic Myotonia</condition>
  <condition>Myotonia Congenita</condition>
  <arm_group>
    <arm_group_label>MC</arm_group_label>
    <description>MC patients with either dominant (Thomsens) or recessive (Becker) myotonia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <description>Healthy controls age- and gender matched.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        40 patients (Thomsens MC, n=20; Beckers MC, n=20) will be included along with 20 healthy&#xD;
        age- and gender-matched controls. Inclusion criteria are age &gt;18 years, verified MC&#xD;
        diagnosis. Exclusion criteria areknown competing disorders that can interfere with the&#xD;
        results (ie. muscular diseases or arthritis) or MRI contraindications.&#xD;
&#xD;
        Before participation patients are asked about medication status. Participants who are&#xD;
        treated for their myotonic symptoms with either Mexiletin or Lamotrigin are asked to pause&#xD;
        their medication four days prior to participation.&#xD;
&#xD;
        All patients will be asked to evaluate the severity of their myotonic symptoms using the&#xD;
        MBS (Myotonic Behaviour Scale) rating from 1 (least severe) to 6 (most severe).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &lt;18 years&#xD;
&#xD;
          -  Molecularly verified MC (Thomsens or Beckers disease)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Conditions that may impair results of the study, evaluated by the investigator&#xD;
&#xD;
          -  Clausphobia&#xD;
&#xD;
          -  Pregnancy or breastfeeding&#xD;
&#xD;
          -  Metallic objects in and around the body that are not MR-compatible&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Jacobsen, BSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rigshospitalet, Denmark</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laura Jacobsen, BSc</last_name>
    <phone>+4535456135</phone>
    <email>laura.noerager.jacobsen.01@regionh.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laura Jacobsen, BSc</last_name>
      <phone>+4535456135</phone>
      <email>laura.noerager.jacobsen.01@regionh.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 11, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 16, 2021</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Laura NÃ¸rager Jacobsen</investigator_full_name>
    <investigator_title>BSc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myotonia Congenita</mesh_term>
    <mesh_term>Myotonia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

